Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-3.39%
6 month change
+50.00%
Jahresänderung
-65.45%
Vorheriger Schlusskurs
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volumen
5
Märkte
Aktien
Gesundheitswesen
FEMY
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
22.9 M
27.15 M
27.24 M
32.58 M
58.48 M
—
Valuation ratios
Enterprise value
17.81 M
26.41 M
30.23 M
28.24 M
16.04 M
100.93 M
Price to earnings ratio
-1.35
-1.29
-1.37
-1.12
-0.49
-4.28
Price to sales ratio
18.13
15.04
16.75
12.25
4.92
48.96
Price to cash flow ratio
-1.31
-1.26
-1.46
-1.19
-0.5
-4.41
Price to book ratio
0.41
10.63
1.31
1.92
1.02
14.87
Enterprise value to EBITDA ratio
-1.1
-1.62
-1.66
-1.62
-1.01
-5.92
Profitability ratios
Return on assets %
-0.35
-0.41
-0.44
-0.33
-0.26
-1.45
Return on equity %
-0.91
-2.22
-2.95
-3.04
-0.92
-9.14
Return on invested capital %
-382.94
-234.26
-208.67
-145.61
-132.51
-721.05
Gross margin %
65.61
66.92
65.64
61.35
59.71
253.62
Operating margin %
-922.39
-812.03
-1 600.11
-941.09
-500.93
-3 854.16
EBITDA margin %
-851.63
-737.75
-1 470.73
-822.98
-428.54
-3 459.99
Net margin %
-974.73
-881
-1 727.94
-1 120.52
-575.11
-4 304.57
Liquidity ratios
Quick ratio
3.26
0.58
0.54
0.41
0.61
2.14
Current ratio
3.94
0.93
0.93
0.89
1.16
3.91
Inventory turnover
0.12
0.08
0.03
0.03
0.05
0.2
Asset turnover
0.03
0.04
0.03
0.03
0.05
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.33
0
0.43
0.44
0.02
0.89
Long term debt to total equity ratio
0.85
0
2.89
4.03
0.06
6.98
Per share metrics
Operating cash flow per share
-0.25
-0.23
-0.19
-0.15
-0.13
-0.7
EBIT per share
-0.23
-0.21
-0.22
-0.13
-0.09
-0.65
EBITDA per share
-0.21
-0.19
-0.2
-0.12
-0.08
-0.59
Total debt per share
—
—
—
—
—
—
Cash per share
0.34
0.16
0.15
0.11
0.11
0.53
Net current asset value per share
0.51
0.36
0.36
0.34
0.3
1.36
Tangible book value per share
0.27
0.1
0.08
0.05
0.11
0.34
Working capital per share
0.38
-0.03
-0.03
-0.04
0.04
-0.05
Book value per share
0.27
0.1
0.08
0.05
0.11
0.35
Nachrichten
Femasys receives CPT code approval for infertility treatment
Femasys-Aktie steigt nach Ankündigung einer Vertriebspartnerschaft in der Schweiz
Femasys expands European presence with Swiss distribution deal
Femasys: NASDAQ verlängert Frist zur Erfüllung der Mindestkurspflicht um 180 Tage
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys: Partnerschaft mit Refuah Health Center soll FemaSeed-Fertilitätsbehandlung ausweiten
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
PharmaCyte-Aktie haussiert nach erfolgreichem Verkauf von Femasys-Beteiligung
PharmaCyte Biotech stock soars after successful Femasys stake sale